Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 07/27 01:26:12 pm
1706 GBp   +2.34%
01:22p GlaxoSmithKline invests 275 million pounds in UK despite Brexit v..
01:22p GSK outlook brightens as Brexit brings currency windfall
01:22p GSK chases next biotech asthma drug with 175 million pounds J&J d..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline plc : Director/PDMR Shareholding

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 08:11pm CEST

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GLAXOSMITHKLINE PLC
01:22p GSK chases next biotech asthma drug with 175 million pounds J&J deal
01:22p GlaxoSmithKline invests 275 million pounds in UK despite Brexit vote
01:22p GSK outlook brightens as Brexit brings currency windfall
01:22p GLAXOSMITHKLINE : Results Announcement for the second quarter 2016 and Half-year..
01:18p TOP NEWS : Glaxo Edges Up Forecasts, Sees No Material Hit From Brexit
12:24p GLAXOSMITHKLINE : Robert Gordon University - Saltire scholarship opportunity for..
08:37a TOP NEWS : GlaxoSmithKline To Invest GBP275 Billion In Three UK Sites
07/22 GLAXOSMITHKLINE PAKISTAN : Loss of Shares of GlaxoSmithKline Pakistan Limited
07/22GLAXOSMITHKLINE PLC : half-yearly earnings release
07/20DJBrexit Fears and Weak Pound Weigh on Corporate Europe
More news
Sector news : Pharmaceuticals - NEC
01:30pDJSANOFI : 2Q 2016 -- Forecast
01:22p GlaxoSmithKline invests 275 million pounds in UK despite Brexit vote
01:22p GSK outlook brightens as Brexit brings currency windfall
01:22p GSK chases next biotech asthma drug with 175 million pounds J&J deal
10:22aDJBAYER : Reports Higher Second-Quarter Profit, Raises Guidance -- Update
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07:28a WALL STREET BREAKFAST : Earnings Season Kicks Into High Gear
07:15a GlaxoSmithKline reports Q2 results
04:36a Glaxo to invest £275M in U.K. despite Brexit
07/26 StarMine Models Pick European Companies For Earnings Beats
07/25 RETIREMENT STRATEGY : 5 Pharmaceutical Dividends To Buy Here
Advertisement
Financials ( GBP)
Sales 2016 26 368 M
EBIT 2016 6 707 M
Net income 2016 2 803 M
Debt 2016 12 843 M
Yield 2016 4,85%
P/E ratio 2016 32,19
P/E ratio 2017 23,39
EV / Sales 2016 3,57x
EV / Sales 2017 3,42x
Capitalization 81 222 M
More Financials
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Average target price 16,4  GBP
Spread / Average Target -1,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Andrew Philip Witty Chief Executive Officer & Executive Director
Philip Roy Hampton Non-Executive Chairman
Simon Dingemans Chief Financial Officer & Executive Director
Moncef Slaoui Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC20.68%106 688
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
More Results